RV

Ravindra Vyankatrao Somatkar

Active Director Director DIN 10970569
DIN 10970569 First appointment Feb 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Ravindra Vyankatrao Somatkar

Data last updated:

Ravindra Vyankatrao Somatkar is a Director at Celltrust Pharma Private Limited (since 2025).

DIN 10970569
Primary Designation Director
First Appointment 25 Feb 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Celltrust Pharma Private Limited U47721MH2025PTC441136
Director25 Feb 20252025Active

Board colleagues of Ravindra Vyankatrao Somatkar

Directorship timeline

Open interactive timeline →
Celltrust Pharma Private Limited
Premium access

Shareholding and investment profile for Ravindra Vyankatrao Somatkar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ravindra Vyankatrao Somatkar

Ravindra Vyankatrao Somatkar currently holds 1 directorship: Celltrust Pharma Private Limited (Director, since 25 Feb 2025).

Ravindra Vyankatrao Somatkar was first appointed on 25 Feb 2025 as Director at Celltrust Pharma Private Limited.

The current boards of Ravindra Vyankatrao Somatkar's companies include Priyanka Khandelwal (Celltrust Pharma Private Limited), Tushar Borkar (Celltrust Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available